It is widely accepted that the EGFR pathway, as well as downstream networks involving MEK‐ERK and PI3K‐AKT, was hyperactivated and played important roles in promoting tumour metastasis of multiple cancers, including HCC.29, 37, 38. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.